Literature DB >> 7018248

A prospective study of group B streptococcal bacteriuria in pregnancy.

E G Wood, H C Dillon.   

Abstract

Bacteriuria in pregnancy was prospectively studied in 569 women, with specific reference to group B streptococcal infection. Forty-six patients (8%) had bacteriuria, including 14 with group B streptococcal infection; group B streptococci (GBS) were exceeded in frequency only by Escherichia coli. Two thirds of the bacteriuric patients remained asymptomatic. The outcome of pregnancy was studied in 41/46 bacteriuric patients, including all those with group B streptococcal infection. Two pregnancies ended in intrauterine fetal death, and one neonate developed group B streptococcal sepsis; all three complications occurred in the 14 women with group B streptococcal bacteriuria. Diabetes mellitus appeared to increase the risk of group B streptococcal bacteriuria. This study revealed that group B streptococcal bacteriuria is more common in pregnancy than was previously suspected and suggests that culture methods to detect GBS should be used in bacteriuria screening programs done in pregnancy. In terms of perinatal infection risk, screening for group B streptococcal bacteriuria at or near the time of delivery may be more meaningful than other group B streptococcal surveillance culture studies.

Entities:  

Mesh:

Year:  1981        PMID: 7018248     DOI: 10.1016/0002-9378(81)90226-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  20 in total

1.  Serine-rich repeat proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract.

Authors:  Tamsin R Sheen; Alyssa Jimenez; Nai-Yu Wang; Anirban Banerjee; Nina M van Sorge; Kelly S Doran
Journal:  J Bacteriol       Date:  2011-10-07       Impact factor: 3.490

2.  Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.

Authors:  Chee K Tan; Alison J Carey; Xiangqin Cui; Richard I Webb; Deepak Ipe; Michael Crowley; Allan W Cripps; William H Benjamin; Kimberly B Ulett; Mark A Schembri; Glen C Ulett
Journal:  Infect Immun       Date:  2012-06-25       Impact factor: 3.441

3.  Detection of bacteria by hybridization of rRNA with DNA-latex and immunodetection of hybrids.

Authors:  C A Miller; W L Patterson; P K Johnson; C T Swartzell; F Wogoman; J P Albarella; R J Carrico
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

4.  What is the risk of beta-haemolytic streptococcal infection in obstetrics?: discussion paper.

Authors:  C S Easmon
Journal:  J R Soc Med       Date:  1984-04       Impact factor: 5.344

5.  Evaluation of the leukocyte esterase and nitrite urine dipstick screening tests for detection of bacteriuria in women with suspected uncomplicated urinary tract infections.

Authors:  H Semeniuk; D Church
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

Review 6.  Early-onset neonatal sepsis.

Authors:  Kari A Simonsen; Ann L Anderson-Berry; Shirley F Delair; H Dele Davies
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

Review 7.  Detection of urinary tract infections by rapid methods.

Authors:  M Pezzlo
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

8.  Diversity of group B streptococcus serotypes causing urinary tract infection in adults.

Authors:  Kimberly B Ulett; William H Benjamin; Fenglin Zhuo; Meng Xiao; Fanrong Kong; Gwendolyn L Gilbert; Mark A Schembri; Glen C Ulett
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

Review 9.  Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis.

Authors:  Joyce M Koenig; William J Keenan
Journal:  Pediatr Clin North Am       Date:  2009-06       Impact factor: 3.278

10.  The in vitro activity of ampicillin, amoxicillin, cephalexin, nitrofurantoin, sulphadiazine and trimethoprim against Streptococcus agalactiae isolated from urinary and other infections.

Authors:  P Brander; L Jokipii; A M Jokipii
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.